AGIOS PHARMACEUTICALS, INC. 10-Q filing
Filed 2026-07-30 · Report date 2026-06-30 · 2026
Filing metadata
- Accession number
- 0001439222-26-000118
- Form type
- 10-Q
- CIK
- 0001439222
- Primary document
- https://www.sec.gov/Archives/edgar/data/1439222/000143922226000118/agio-20260630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AGIOS PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $65.5M | - | - |
| Cost Of Revenue | $4.3M | - | - |
| Operating Income | $-220.6M | - | - |
| Net Income | $-199.8M | - | - |
| Eps Basic | -3.38 | - | - |
| Eps Diluted | -3.38 | - | - |
| Cash And Equivalents | $99.6M | - | - |
| Total Assets | $1.1B | - | - |
| Total Liabilities | $82.4M | - | - |
| Shareholders Equity | $1.0B | - | - |
| Operating Cash Flow | $-176.2M | - | - |
| Capital Expenditures | $2.0M | - | - |